nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—HTR1D—meninx—malignant glioma	0.17	0.21	CbGeAlD
Xylometazoline—HTR1B—dura mater—malignant glioma	0.161	0.199	CbGeAlD
Xylometazoline—HTR1D—dura mater—malignant glioma	0.156	0.193	CbGeAlD
Xylometazoline—HTR1B—telencephalic ventricle—malignant glioma	0.0402	0.0497	CbGeAlD
Xylometazoline—HTR1D—telencephalic ventricle—malignant glioma	0.0389	0.0481	CbGeAlD
Xylometazoline—HTR1B—blood vessel—malignant glioma	0.0199	0.0246	CbGeAlD
Xylometazoline—HTR1D—blood vessel—malignant glioma	0.0193	0.0238	CbGeAlD
Xylometazoline—ADRA1D—telencephalon—malignant glioma	0.0125	0.0154	CbGeAlD
Xylometazoline—HTR1B—brainstem—malignant glioma	0.0109	0.0134	CbGeAlD
Xylometazoline—HTR1D—brainstem—malignant glioma	0.0105	0.013	CbGeAlD
Xylometazoline—HTR1B—telencephalon—malignant glioma	0.00965	0.0119	CbGeAlD
Xylometazoline—HTR1D—telencephalon—malignant glioma	0.00934	0.0115	CbGeAlD
Xylometazoline—ADRA1A—brainstem—malignant glioma	0.00809	0.01	CbGeAlD
Xylometazoline—ADRA1B—central nervous system—malignant glioma	0.00726	0.00897	CbGeAlD
Xylometazoline—ADRA1A—telencephalon—malignant glioma	0.00718	0.00887	CbGeAlD
Xylometazoline—ADRA1D—central nervous system—malignant glioma	0.0071	0.00878	CbGeAlD
Xylometazoline—HTR1B—midbrain—malignant glioma	0.00693	0.00856	CbGeAlD
Xylometazoline—ADRA2C—telencephalon—malignant glioma	0.00684	0.00845	CbGeAlD
Xylometazoline—HTR1B—spinal cord—malignant glioma	0.00676	0.00835	CbGeAlD
Xylometazoline—HTR1D—midbrain—malignant glioma	0.00671	0.00829	CbGeAlD
Xylometazoline—ADRA1B—brain—malignant glioma	0.00577	0.00712	CbGeAlD
Xylometazoline—ADRA1D—brain—malignant glioma	0.00564	0.00697	CbGeAlD
Xylometazoline—HTR1B—central nervous system—malignant glioma	0.00549	0.00678	CbGeAlD
Xylometazoline—ADRA2A—telencephalon—malignant glioma	0.00546	0.00674	CbGeAlD
Xylometazoline—ADRA2C—medulla oblongata—malignant glioma	0.00537	0.00664	CbGeAlD
Xylometazoline—HTR1D—central nervous system—malignant glioma	0.00531	0.00656	CbGeAlD
Xylometazoline—ADRA2C—midbrain—malignant glioma	0.00491	0.00607	CbGeAlD
Xylometazoline—ADRA2C—spinal cord—malignant glioma	0.00479	0.00592	CbGeAlD
Xylometazoline—HTR1B—brain—malignant glioma	0.00435	0.00538	CbGeAlD
Xylometazoline—ADRA2A—medulla oblongata—malignant glioma	0.00429	0.0053	CbGeAlD
Xylometazoline—HTR1D—brain—malignant glioma	0.00422	0.00521	CbGeAlD
Xylometazoline—ADRA1A—central nervous system—malignant glioma	0.00408	0.00504	CbGeAlD
Xylometazoline—ADRA1A—cerebellum—malignant glioma	0.00399	0.00493	CbGeAlD
Xylometazoline—ADRA2A—midbrain—malignant glioma	0.00392	0.00484	CbGeAlD
Xylometazoline—ADRA2C—central nervous system—malignant glioma	0.00389	0.0048	CbGeAlD
Xylometazoline—ADRA2A—spinal cord—malignant glioma	0.00382	0.00473	CbGeAlD
Xylometazoline—ADRA2C—cerebellum—malignant glioma	0.0038	0.0047	CbGeAlD
Xylometazoline—ADRA1A—brain—malignant glioma	0.00324	0.004	CbGeAlD
Xylometazoline—ADRA2A—central nervous system—malignant glioma	0.0031	0.00383	CbGeAlD
Xylometazoline—ADRA2C—brain—malignant glioma	0.00309	0.00381	CbGeAlD
Xylometazoline—ADRA2A—cerebellum—malignant glioma	0.00303	0.00375	CbGeAlD
Xylometazoline—ADRA2A—brain—malignant glioma	0.00246	0.00304	CbGeAlD
Xylometazoline—ADRA2C—Signaling Pathways—BAD—malignant glioma	4.48e-05	0.000235	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—PIK3CA—malignant glioma	4.48e-05	0.000235	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—F2—malignant glioma	4.46e-05	0.000234	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—FN1—malignant glioma	4.46e-05	0.000234	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NOTCH1—malignant glioma	4.44e-05	0.000233	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—KRAS—malignant glioma	4.43e-05	0.000232	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CXCL8—malignant glioma	4.42e-05	0.000232	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SPP1—malignant glioma	4.41e-05	0.000231	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—BAD—malignant glioma	4.41e-05	0.000231	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PDGFB—malignant glioma	4.39e-05	0.00023	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CXCL8—malignant glioma	4.39e-05	0.00023	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—FGFR1—malignant glioma	4.37e-05	0.000229	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NOTCH1—malignant glioma	4.37e-05	0.000229	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—BRAF—malignant glioma	4.36e-05	0.000229	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CD80—malignant glioma	4.35e-05	0.000228	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CG—malignant glioma	4.34e-05	0.000227	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—APC—malignant glioma	4.34e-05	0.000227	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CXCL8—malignant glioma	4.33e-05	0.000227	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—FGF2—malignant glioma	4.33e-05	0.000227	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HIF1A—malignant glioma	4.3e-05	0.000226	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EGF—malignant glioma	4.29e-05	0.000225	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CD80—malignant glioma	4.28e-05	0.000224	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—AKT1—malignant glioma	4.27e-05	0.000224	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—APC—malignant glioma	4.27e-05	0.000224	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CG—malignant glioma	4.27e-05	0.000224	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PTPN11—malignant glioma	4.26e-05	0.000223	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AKT2—malignant glioma	4.25e-05	0.000223	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CASP3—malignant glioma	4.24e-05	0.000222	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—EGFR—malignant glioma	4.23e-05	0.000222	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL2—malignant glioma	4.23e-05	0.000222	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EGF—malignant glioma	4.22e-05	0.000221	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CG—malignant glioma	4.21e-05	0.000221	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL2—malignant glioma	4.2e-05	0.00022	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PTPN11—malignant glioma	4.19e-05	0.00022	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—AKT1—malignant glioma	4.19e-05	0.000219	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TERT—malignant glioma	4.18e-05	0.000219	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CAV1—malignant glioma	4.16e-05	0.000218	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CASP3—malignant glioma	4.15e-05	0.000217	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL2—malignant glioma	4.14e-05	0.000217	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—KDR—malignant glioma	4.12e-05	0.000216	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CD—malignant glioma	4.08e-05	0.000214	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PDGFB—malignant glioma	4.08e-05	0.000214	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—BRAF—malignant glioma	4.08e-05	0.000214	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—PIK3CA—malignant glioma	4.07e-05	0.000213	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PPARG—malignant glioma	4.07e-05	0.000213	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—FGFR1—malignant glioma	4.06e-05	0.000213	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MDM2—malignant glioma	4.05e-05	0.000212	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—PIK3CA—malignant glioma	4.04e-05	0.000212	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—RAF1—malignant glioma	4.04e-05	0.000212	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—BRAF—malignant glioma	4.01e-05	0.00021	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MMP9—malignant glioma	4e-05	0.00021	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HIF1A—malignant glioma	4e-05	0.00021	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—KRAS—malignant glioma	4e-05	0.00021	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ERBB2—malignant glioma	3.99e-05	0.000209	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PTEN—malignant glioma	3.98e-05	0.000209	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PIK3CB—malignant glioma	3.97e-05	0.000208	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AKT2—malignant glioma	3.97e-05	0.000208	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—AKT1—malignant glioma	3.97e-05	0.000208	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—FN1—malignant glioma	3.96e-05	0.000208	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—F2—malignant glioma	3.96e-05	0.000208	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—EGFR—malignant glioma	3.95e-05	0.000207	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PIK3CB—malignant glioma	3.94e-05	0.000207	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PTGS2—malignant glioma	3.94e-05	0.000207	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MMP9—malignant glioma	3.92e-05	0.000206	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—BAD—malignant glioma	3.91e-05	0.000205	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—FGF2—malignant glioma	3.91e-05	0.000205	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AKT2—malignant glioma	3.91e-05	0.000205	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PTEN—malignant glioma	3.9e-05	0.000204	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—EGFR—malignant glioma	3.89e-05	0.000204	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—AKT1—malignant glioma	3.88e-05	0.000204	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	3.88e-05	0.000203	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CAV1—malignant glioma	3.87e-05	0.000203	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—KDR—malignant glioma	3.82e-05	0.000201	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CD—malignant glioma	3.81e-05	0.0002	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—AKT1—malignant glioma	3.8e-05	0.000199	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CD80—malignant glioma	3.8e-05	0.000199	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	3.79e-05	0.000199	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—APC—malignant glioma	3.79e-05	0.000199	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CXCL8—malignant glioma	3.79e-05	0.000199	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—PIK3CA—malignant glioma	3.78e-05	0.000198	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CD—malignant glioma	3.75e-05	0.000197	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EGF—malignant glioma	3.75e-05	0.000197	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—KRAS—malignant glioma	3.73e-05	0.000196	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	3.73e-05	0.000195	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—PIK3CA—malignant glioma	3.72e-05	0.000195	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CD—malignant glioma	3.7e-05	0.000194	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—F2—malignant glioma	3.68e-05	0.000193	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—FN1—malignant glioma	3.68e-05	0.000193	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—KRAS—malignant glioma	3.67e-05	0.000193	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—PIK3CA—malignant glioma	3.67e-05	0.000193	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—AKT1—malignant glioma	3.66e-05	0.000192	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MDM2—malignant glioma	3.66e-05	0.000192	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—FGF2—malignant glioma	3.65e-05	0.000191	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—RAF1—malignant glioma	3.64e-05	0.000191	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—BAD—malignant glioma	3.64e-05	0.000191	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CASP3—malignant glioma	3.62e-05	0.00019	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL2—malignant glioma	3.62e-05	0.00019	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ERBB2—malignant glioma	3.61e-05	0.000189	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NOTCH1—malignant glioma	3.6e-05	0.000189	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—VEGFA—malignant glioma	3.59e-05	0.000188	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—FGF2—malignant glioma	3.59e-05	0.000188	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—BRAF—malignant glioma	3.56e-05	0.000187	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—STAT3—malignant glioma	3.56e-05	0.000187	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CB—malignant glioma	3.56e-05	0.000187	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CD80—malignant glioma	3.53e-05	0.000185	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APC—malignant glioma	3.52e-05	0.000185	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	3.52e-05	0.000185	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—VEGFA—malignant glioma	3.52e-05	0.000185	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—STAT3—malignant glioma	3.48e-05	0.000183	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EGF—malignant glioma	3.48e-05	0.000183	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AKT2—malignant glioma	3.47e-05	0.000182	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	3.46e-05	0.000182	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	3.45e-05	0.000181	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PTEN—malignant glioma	3.43e-05	0.00018	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—PIK3CA—malignant glioma	3.43e-05	0.00018	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MMP9—malignant glioma	3.43e-05	0.00018	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CXCL8—malignant glioma	3.42e-05	0.000179	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MDM2—malignant glioma	3.42e-05	0.000179	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PTEN—malignant glioma	3.41e-05	0.000179	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—RAF1—malignant glioma	3.4e-05	0.000179	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—PIK3CA—malignant glioma	3.38e-05	0.000177	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ERBB2—malignant glioma	3.37e-05	0.000177	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MDM2—malignant glioma	3.36e-05	0.000176	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—RAF1—malignant glioma	3.35e-05	0.000176	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	3.33e-05	0.000175	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CB—malignant glioma	3.32e-05	0.000174	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AKT1—malignant glioma	3.32e-05	0.000174	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	3.31e-05	0.000174	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—BRAF—malignant glioma	3.31e-05	0.000174	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MYC—malignant glioma	3.31e-05	0.000173	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	3.3e-05	0.000173	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	3.3e-05	0.000173	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CASP3—malignant glioma	3.27e-05	0.000172	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	3.27e-05	0.000172	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL2—malignant glioma	3.27e-05	0.000171	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	3.26e-05	0.000171	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MYC—malignant glioma	3.24e-05	0.00017	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EGFR—malignant glioma	3.23e-05	0.00017	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CB—malignant glioma	3.23e-05	0.000169	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AKT2—malignant glioma	3.22e-05	0.000169	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	3.21e-05	0.000168	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTGS2—malignant glioma	3.2e-05	0.000168	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CXCL8—malignant glioma	3.19e-05	0.000167	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—FGF2—malignant glioma	3.19e-05	0.000167	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EGFR—malignant glioma	3.17e-05	0.000166	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	3.14e-05	0.000165	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	3.1e-05	0.000162	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MMP9—malignant glioma	3.09e-05	0.000162	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	3.09e-05	0.000162	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—VEGFA—malignant glioma	3.08e-05	0.000161	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PTEN—malignant glioma	3.07e-05	0.000161	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	3.07e-05	0.000161	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CASP3—malignant glioma	3.06e-05	0.00016	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—KRAS—malignant glioma	3.06e-05	0.00016	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL2—malignant glioma	3.05e-05	0.00016	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—STAT3—malignant glioma	3.05e-05	0.00016	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	3.04e-05	0.000159	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	3.03e-05	0.000159	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CASP3—malignant glioma	3.01e-05	0.000158	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL2—malignant glioma	3e-05	0.000158	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	3e-05	0.000157	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	3e-05	0.000157	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—KRAS—malignant glioma	2.99e-05	0.000157	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MDM2—malignant glioma	2.99e-05	0.000157	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—RAF1—malignant glioma	2.98e-05	0.000156	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—FGF2—malignant glioma	2.97e-05	0.000156	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	2.94e-05	0.000154	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	2.91e-05	0.000152	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MMP9—malignant glioma	2.89e-05	0.000151	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PTEN—malignant glioma	2.87e-05	0.000151	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MMP9—malignant glioma	2.84e-05	0.000149	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MYC—malignant glioma	2.83e-05	0.000148	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PTEN—malignant glioma	2.83e-05	0.000148	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	2.81e-05	0.000147	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	2.8e-05	0.000147	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	2.79e-05	0.000146	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTEN—malignant glioma	2.79e-05	0.000146	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	2.79e-05	0.000146	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	2.78e-05	0.000146	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MDM2—malignant glioma	2.77e-05	0.000146	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EGFR—malignant glioma	2.77e-05	0.000145	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—RAF1—malignant glioma	2.76e-05	0.000145	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	2.76e-05	0.000145	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—STAT3—malignant glioma	2.75e-05	0.000144	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	2.75e-05	0.000144	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	2.74e-05	0.000143	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TP53—malignant glioma	2.72e-05	0.000142	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	2.7e-05	0.000142	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	2.7e-05	0.000141	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CASP3—malignant glioma	2.67e-05	0.00014	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL2—malignant glioma	2.67e-05	0.00014	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TP53—malignant glioma	2.66e-05	0.000139	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—KRAS—malignant glioma	2.61e-05	0.000137	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	2.59e-05	0.000136	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	2.59e-05	0.000136	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—STAT3—malignant glioma	2.57e-05	0.000135	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MYC—malignant glioma	2.55e-05	0.000134	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	2.55e-05	0.000134	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—STAT3—malignant glioma	2.53e-05	0.000133	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MMP9—malignant glioma	2.53e-05	0.000132	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PTEN—malignant glioma	2.51e-05	0.000132	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	2.51e-05	0.000131	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EGFR—malignant glioma	2.5e-05	0.000131	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CASP3—malignant glioma	2.48e-05	0.00013	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL2—malignant glioma	2.48e-05	0.00013	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	2.45e-05	0.000128	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PIK3CA—malignant glioma	2.42e-05	0.000127	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	2.4e-05	0.000126	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MYC—malignant glioma	2.39e-05	0.000125	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—KRAS—malignant glioma	2.36e-05	0.000124	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MYC—malignant glioma	2.35e-05	0.000123	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MMP9—malignant glioma	2.35e-05	0.000123	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EGFR—malignant glioma	2.33e-05	0.000122	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PTEN—malignant glioma	2.33e-05	0.000122	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TP53—malignant glioma	2.32e-05	0.000122	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EGFR—malignant glioma	2.3e-05	0.00012	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AKT1—malignant glioma	2.29e-05	0.00012	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	2.28e-05	0.000119	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	2.27e-05	0.000119	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AKT1—malignant glioma	2.25e-05	0.000118	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—STAT3—malignant glioma	2.25e-05	0.000118	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—KRAS—malignant glioma	2.21e-05	0.000116	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—KRAS—malignant glioma	2.17e-05	0.000114	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	2.17e-05	0.000114	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	2.11e-05	0.00011	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TP53—malignant glioma	2.1e-05	0.00011	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MYC—malignant glioma	2.09e-05	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—STAT3—malignant glioma	2.09e-05	0.000109	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EGFR—malignant glioma	2.04e-05	0.000107	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	2.03e-05	0.000106	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	1.99e-05	0.000105	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—AKT1—malignant glioma	1.98e-05	0.000104	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CA—malignant glioma	1.97e-05	0.000103	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AKT1—malignant glioma	1.96e-05	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TP53—malignant glioma	1.96e-05	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MYC—malignant glioma	1.94e-05	0.000102	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TP53—malignant glioma	1.93e-05	0.000101	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—KRAS—malignant glioma	1.93e-05	0.000101	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EGFR—malignant glioma	1.9e-05	9.94e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—KRAS—malignant glioma	1.79e-05	9.39e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AKT1—malignant glioma	1.77e-05	9.29e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	1.77e-05	9.29e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TP53—malignant glioma	1.71e-05	8.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AKT1—malignant glioma	1.66e-05	8.68e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	1.65e-05	8.63e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AKT1—malignant glioma	1.63e-05	8.54e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AKT1—malignant glioma	1.61e-05	8.43e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TP53—malignant glioma	1.59e-05	8.35e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AKT1—malignant glioma	1.45e-05	7.59e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AKT1—malignant glioma	1.34e-05	7.05e-05	CbGpPWpGaD
